220 related articles for article (PubMed ID: 18288090)
1. Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
Perlis RH; Moorjani P; Fagerness J; Purcell S; Trivedi MH; Fava M; Rush AJ; Smoller JW
Neuropsychopharmacology; 2008 Nov; 33(12):2810-9. PubMed ID: 18288090
[TBL] [Abstract][Full Text] [Related]
2. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW
Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750
[TBL] [Abstract][Full Text] [Related]
3. The role of the potassium channel gene KCNK2 in major depressive disorder.
Congiu C; Minelli A; Bonvicini C; Bortolomasi M; Sartori R; Maj C; Scassellati C; Maina G; Trabucchi L; Segala M; Gennarelli M
Psychiatry Res; 2015 Feb; 225(3):489-92. PubMed ID: 25535009
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
Binder EB; Owens MJ; Liu W; Deveau TC; Rush AJ; Trivedi MH; Fava M; Bradley B; Ressler KJ; Nemeroff CB
Arch Gen Psychiatry; 2010 Apr; 67(4):369-79. PubMed ID: 20368512
[TBL] [Abstract][Full Text] [Related]
5. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
Gaynes BN; Rush AJ; Trivedi MH; Wisniewski SR; Balasubramani GK; McGrath PJ; Thase ME; Klinkman M; Nierenberg AA; Yates WR; Fava M
J Gen Intern Med; 2008 May; 23(5):551-60. PubMed ID: 18247097
[TBL] [Abstract][Full Text] [Related]
6. SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
Shiroma PR; Drews MS; Geske JR; Mrazek DA
Am J Geriatr Psychiatry; 2014 Nov; 22(11):1140-8. PubMed ID: 23973251
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
[TBL] [Abstract][Full Text] [Related]
8. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
9. Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.
Cutler JA; Rush AJ; McMahon FJ; Laje G
J Psychopharmacol; 2012 Mar; 26(3):360-7. PubMed ID: 22282879
[TBL] [Abstract][Full Text] [Related]
10. Chronic citalopram treatment elevates serotonin synthesis in flinders sensitive and flinders resistant lines of rats, with no significant effect on Sprague-Dawley rats.
Kanemaru K; Nishi K; Hasegawa S; Diksic M
Neurochem Int; 2009; 54(5-6):363-71. PubMed ID: 19418630
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.
Mrazek DA; Biernacka JM; McAlpine DE; Benitez J; Karpyak VM; Williams MD; Hall-Flavin DK; Netzel PJ; Passov V; Rohland BM; Shinozaki G; Hoberg AA; Snyder KA; Drews MS; Skime MK; Sagen JA; Schaid DJ; Weinshilboum R; Katzelnick DJ
J Clin Psychopharmacol; 2014 Jun; 34(3):313-7. PubMed ID: 24743713
[TBL] [Abstract][Full Text] [Related]
12. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.
Kraft JB; Peters EJ; Slager SL; Jenkins GD; Reinalda MS; McGrath PJ; Hamilton SP
Biol Psychiatry; 2007 Mar; 61(6):734-42. PubMed ID: 17123473
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
Tsai SJ; Hong CJ; Liou YJ; Yu YW; Chen TJ; Hou SJ; Yen FC
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):637-41. PubMed ID: 19272410
[TBL] [Abstract][Full Text] [Related]
14. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
Paddock S; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ
Am J Psychiatry; 2007 Aug; 164(8):1181-8. PubMed ID: 17671280
[TBL] [Abstract][Full Text] [Related]
15. What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.
Rush AJ; South C; Jha MK; Jain SB; Trivedi MH
J Clin Psychiatry; 2020 Aug; 81(5):. PubMed ID: 32780949
[TBL] [Abstract][Full Text] [Related]
16. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.
Katz AJ; Dusetzina SB; Farley JF; Ellis AR; Gaynes BN; Castillo WC; Stürmer T; Hansen RA
Pharmacotherapy; 2012 Mar; 32(3):234-43. PubMed ID: 22392456
[TBL] [Abstract][Full Text] [Related]
17. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.
Perlis RH; Laje G; Smoller JW; Fava M; Rush AJ; McMahon FJ
Neuropsychopharmacology; 2009 Jun; 34(7):1819-28. PubMed ID: 19295509
[TBL] [Abstract][Full Text] [Related]
18. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
Laje G; Perlis RH; Rush AJ; McMahon FJ
Psychiatr Serv; 2009 Nov; 60(11):1446-57. PubMed ID: 19880459
[TBL] [Abstract][Full Text] [Related]
20. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
